Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

CYR61/CCN1

  • Yalin Emre
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101754

Synonyms

Historical Background

CYR61/CCN1 belongs to the family of CCN matricellular proteins, first described 25 years ago. The other members consist of CTGF/CCN2 (connective tissue growth factor) and NOV/CCN3 (neuroblastoma overexpressed) and Wnt-induced signaling pathway proteins 1–3 (CCN4–CCN6). They constitute a family of proteins with conserved domain structures (Fig. 1). CCN1 was first described as an immediate early gene induced by mitogens in fibroblasts (O’Brien et al. 1990). It has now been implicated in numerous biological processes such as cell adhesion, migration, proliferation, and death with altered expression in cancer or vascular diseases (Emre and Imhof 2014).
This is a preview of subscription content, log in to check access.

References

  1. Amir-Moazami O, Emre Y. Matricellular protein CCN1/CYR61 boosts T-cell output. Med Sci: M/S. 2016;32:144–6. doi:10.1051/medsci/20163202003.CrossRefGoogle Scholar
  2. Chen CC, Kim KH, Lau LF. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene. 2016;35:1314–23. doi:10.1038/onc.2015.190.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Choi JS, Kim KH, Lau LF. The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol. 2015;8:1285–96. doi:10.1038/mi.2015.19.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Emre Y, Imhof BA. Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking. Semin Immunopathol. 2014;36:253–9. doi:10.1007/s00281-014-0420-1.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Emre Y, Irla M, Dunand-Sauthier I, Ballet R, Meguenani M, Jemelin S, Vesin C, Reith W, Imhof BA. Thymic epithelial cell expansion through matricellular protein CYR61 boosts progenitor homing and T-cell output. Nat Commun. 2013;4:2842. doi:10.1038/ncomms3842.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Huang YT, Lan Q, Ponsonnet L, Blanquet M, Christofori G, Zaric J, Ruegg C. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression. Oncotarget. 2016;7:1663–74. doi:10.18632/oncotarget.6411.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Imhof BA, Jemelin S, Ballet R, Vesin C, Schapira M, Karaca M, Emre Y. CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation. Proc Natl Acad Sci U S A. 2016;113:E4847–56. doi:10.1073/pnas.1607710113.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12:676–85. doi:10.1038/ncb2070.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Jun JI, Kim KH, Lau LF. The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing. Nat Commun. 2015;6:7386. doi:10.1038/ncomms8386.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Kim KH, Chen CC, Monzon RI, Lau LF. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol. 2013;33:2078–90. doi:10.1128/MCB.00049-13.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Kim KH, Chen CC, Alpini G, Lau LF. CCN1 induces hepatic ductular reaction through integrin alphavbeta(5)-mediated activation of NF-kappaB. J Clin Invest. 2015;125:1886–900. doi:10.1172/JCI79327.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Lau LF. Cell surface receptors for CCN proteins. J Cell Commun Signal. 2016;10:121–7. doi:10.1007/s12079-016-0324-z.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Li J, Ye L, Owen S, Weeks HP, Zhang Z, Jiang WG. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med. 2015;36:1451–63. doi:10.3892/ijmm.2015.2390.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Lobel M, Bauer S, Meisel C, Eisenreich A, Kudernatsch R, Tank J, Rauch U, Kuhl U, Schultheiss HP, Volk HD, Poller W, Scheibenbogen C. CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci: CMLS. 2012;69:3101–13. doi:10.1007/s00018-012-0981-x.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 2002;22:8709–20.PubMedPubMedCentralCrossRefGoogle Scholar
  16. O’Brien TP, Yang GP, Sanders L, Lau LF. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol. 1990;10:3569–77.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Xu T, He YH, Wang MQ, Yao HW, Ni MM, Zhang L, Meng XM, Huang C, Ge YX, Li J. Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis. Gene. 2016;592:179–85. doi:10.1016/j.gene.2016.07.053.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Yang GP, Lau LF. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ: The Mol Biol J Am Assoc Cancer Res. 1991;2:351–7.Google Scholar
  19. Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, Ouyang G, Lin J, Shen B, Shi Y, Zhang Y, Li D, Li N. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2009;60:3602–12. doi:10.1002/art.24999.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Zhu X, Xiao L, Huo R, Zhang J, Lin J, Xie J, Sun S, He Y, Sun Y, Zhou Z, Shen B, Li N. Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2013;15:R187. doi:10.1186/ar4377.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Pathology and ImmunologyUniversity of GenevaGenevaSwitzerland